Skip to content

Early thyroid-stimulating hormone dynamics predict outcomes in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Oct 2026 · Surgery today (Print) · 0 citations · 29 references
Medicine
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.